HCV (Hepatitis C Antibody) CLIA

Overview:
The HCV (Hepatitis C Antibody) CLIA test is a diagnostic test used to detect antibodies against the Hepatitis C virus (HCV) in the blood. The presence of these antibodies indicates a past or current infection with HCV. CLIA (Chemiluminescent Immunoassay) is the method used, providing a high level of sensitivity and accuracy.

What it detects:
This test detects the antibodies produced by the body in response to a Hepatitis C infection. A positive result means that the individual has been exposed to the virus at some point, but it does not confirm whether the infection is active or chronic. Further testing, such as HCV RNA testing, is needed to confirm active infection.

Who should get it:
Individuals who have had potential exposure to Hepatitis C, such as through intravenous drug use, unprotected sex, or blood transfusions before 1992, may need this test. It is also useful for individuals showing symptoms of Hepatitis C, such as fatigue, jaundice, or unexplained liver abnormalities.

Sample required:
A blood sample is required for this test.

Fasting requirements:
Fasting is not required for this test.

Processing time:
Results available within 24-48 hours.